{"organizations": ["NYU Langone Medical Center", "Seno Medical Instruments, Inc.", "AcelRx Pharmaceuticals, Inc.", "Valeant Pharmaceuticals International, Inc.", "Assume New Board Level Role", "WeissLaw LLP", "International Society of Hair Restoration Surgery", "Campbell", "Perlmutter Cancer Center", "Synergetics USA Inc", "Seno Medical Instruments", "Pearl Therapeutics Inc.", "American Pain Society Pearl Therapeutics"], "uuid": "967903ce65ba3154766e9f745df907c520d3df2e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Theradome-LH80-PRO-Laser-Helmet-Launches-at-the-23rd-Annual-Scientific-Meeting-of-the-International-Society-of-Hair-Restoration-Surgery-48180-1/", "country": "US", "title": "Theradome LH80 PRO Laser Helmet Launches at the 23rd Annual Scientific Meeting of the International Society of Hair Restoration Surgery", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Theradome LH80 PRO Laser Helmet Launches at the 23rd Annual Scientific Meeting of the International Society of Hair Restoration Surgery", "spam_score": 0.0, "site_type": "news", "published": "2015-09-09T12:16:00.000+03:00", "replies_count": 0, "uuid": "967903ce65ba3154766e9f745df907c520d3df2e"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Theradome-LH80-PRO-Laser-Helmet-Launches-at-the-23rd-Annual-Scientific-Meeting-of-the-International-Society-of-Hair-Restoration-Surgery-48180-1/", "ord_in_thread": 0, "title": "Theradome LH80 PRO Laser Helmet Launches at the 23rd Annual Scientific Meeting of the International Society of Hair Restoration Surgery", "locations": ["Spiriva", "Calif.", "Foradil"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Campbell", "Janet Campbell", "Seno"], "text": "  , Sept. 9, 2015 Immunotherapy expert ... and research findings have brought innovative advances in melanoma ... the senior faculty of NYU Langone Medical Center and ... the country,s elite cancer centers designated by the National ... director of the Perlmutter Cancer Center and co-director of   -- Seno Medical Instruments, Inc., a medical device company ... breast diagnostic imaging, today announced that its founder and ... down from her current role. Campbell launched Seno ten ... after a successful career in the medical device industry ... Ms. Campbell developed the first commercial opto-acoustic clinical device   Sept. 9, 2015 The fairness of the proposed ... (\"SURG\" or the \"Company\") by Valeant Pharmaceuticals International, Inc. ... a national class action, shareholder rights law firm. The ... and other violations of law by the Board of ... to Valeant. On September 2, 2015, the Company announced it ... [ 0 ] Renowned Melanoma and Immunotherapy Expert Joins NYU Langone Medical Center [ 0 ] Seno Medical Instruments CEO Janet Campbell to Step Down and Assume New Board Level Role [ 0 ] WeissLaw LLP Investigates the Synergetics USA Inc. Acquisition ... May 18, 2011 AcelRx Pharmaceuticals, Inc. announced ... clinical studies related to two product candidates, ARX-01 ... solve the problems associated with post-operative intravenous patient-controlled ... reduction and pain relief for patients undergoing painful ... ... Calif., May 18, 2011 Pearl Therapeutics Inc. presented ... phase 2b study of PT003 (GFF ... late-breaker poster session at the annual meeting of the ... combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA), ... ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD  ", "external_links": [], "published": "2015-09-09T12:16:00.000+03:00", "crawled": "2015-09-10T01:30:50.590+03:00", "highlightTitle": ""}